Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
TScan Therapeutics (TCRX)
NASDAQ:TCRX
TScan Therapeutics (TCRX) Ownership - Who Owns TScan Therapeutics?
147 Followers
TScan Therapeutics (TCRX) Ownership Overview
24.03% Insiders
6.32% Mutual Funds
7.76% Other Institutional Investors
61.88% Public Companies and
Individual Investors
The ownership structure of TScan Therapeutics (TCRX) stock is a mix of institutional, retail and individual investors. Approximately 14.08% of the company’s stock is owned by Institutional Investors, 24.03% is owned by Insiders and 61.88% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
Date | Name | Activity | Value |
|---|---|---|---|
| Dec 21, 2023 | Timothy Barberich Director | Bought | $142263 |
| Dec 18, 2023 | Barbara Klencke Director | Bought | $25400 |
| Jun 06, 2023 | Timothy Barberich Director | Bought | $99246 |
| Jun 02, 2023 | Lynx1 Capital Management Lp >10% Owner | Sold | $63900 |
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,784,792 | Institution | 6.38% | 19,855,567 | |
| 1,747,918 | Institution | 4.01% | 12,462,655 | |
| 1,726,127 | Institution | 3.96% | 12,307,286 | |
| 1,046,916 | Institution | 2.40% | 7,464,511 | |
| 551,194 | Institution | 1.26% | 3,930,013 | |
| 497,204 | Institution | 1.14% | 3,545,065 | |
| 316,254 | Institution | 0.72% | 2,254,891 | |
| 88,300 | Institution | 0.20% | 629,579 | |
| 57,207 | Institution | 0.13% | 407,886 | |
| 34,201 | Institution | 0.08% | 243,853 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,726,127 | Institution | 3.96% | 12,307,286 | |
| 551,194 | Institution | 1.26% | 3,930,013 | |
| 316,254 | Institution | 0.72% | 2,254,891 | |
| 88,300 | Institution | 0.20% | 629,579 | |
| 27,200 | Institution | 0.06% | 193,936 | |
| 22,104 | Institution | 0.05% | 157,602 | |
| 19,120 | Institution | 0.04% | 136,326 | |
| 6,594 | Institution | 0.02% | 47,015 | |
| 684 | Institution | <0.01% | 4,877 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 1,192,725 | Institution | 2.73% | 9,470,237 | |
| 1,046,916 | Institution | 2.40% | 8,050,784 | |
| 555,193 | Institution | 1.27% | 4,408,232 | |
| 497,204 | Institution | 1.14% | 3,545,065 | |
| 57,207 | Institution | 0.13% | 407,886 | |
| 34,201 | Institution | 0.08% | 263,006 | |
| 2,144 | Institution | <0.01% | 16,616 | |
| 1,383 | Institution | <0.01% | 10,718 | |
| 372 | Institution | <0.01% | 2,883 |
FAQ
Who Owns TScan Therapeutics (TCRX)?
According to the latest TipRanks data, approximately 7.76% of the company's stock is held by institutional investors, 24.03% is held by insiders, and 61.88% is held by retail investors.
What percentage of TScan Therapeutics (TCRX) stock is held by institutional investors?
According to the latest TipRanks data, approximately 7.76% of TScan Therapeutics (TCRX) stock is held by institutional investors.
What percentage of TScan Therapeutics (TCRX) stock is held by retail investors?
According to the latest TipRanks data, approximately 61.88% of TScan Therapeutics (TCRX) stock is held by retail investors.
Who owns the most shares of TScan Therapeutics (TCRX)?
Felix Baker owns the most shares of TScan Therapeutics (TCRX).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.